Call us now
Send InquiryTenohep Af Tablets
Price 850 INR/ Pack
MOQ : 10 Packs
Tenohep Af Tablets Specification
- Medicine Type
- Allopathic
- Appearance
- Film-coated tablet
- Dosage
- 25 mg
- Grade
- Medicine Grade
- Usage
- Anti-HIV treatment
- CAS No
- 197922-42-2
- Indication
- Chronic Hepatitis B
- Molecular Formula
- C21H29N6O5P
- Dosage Form
- Tablet
- Storage
- Store below 30C
- Pacakaging (Quantity Per Box)
- 30 Tablets
- Salt Composition
- Tenofovir Alafenamide 25 mg
- Origin of Medicine
- India
- Expiration Date
- 24 months from manufacture
- Manufacture By
- Zydus Cadila
- Shelf Life
- 2 years
- Route of Administration
- Oral
- Packaging Type
- Bottle
- Unit Dose
- 25 mg/tab
- Colour
- Yellow
- Prescription Required
- Yes
- Generic Name
- Tenofovir Alafenamide
Tenohep Af Tablets Trade Information
- Minimum Order Quantity
- 10 Packs
- Payment Terms
- Cash in Advance (CID)
- Supply Ability
- 5000 Packs Per Month
- Delivery Time
- 2-10 Days
- Main Domestic Market
- All India
About Tenohep Af Tablets
Tenohep AF Tablets, manufactured by Zydus Cadila, are a top-rated, allopathic medicine formulated with the eminent generic ingredient Tenofovir Alafenamide (25 mg/tab). Highlighted for their anti-HIV effectiveness and championed in the treatment of chronic Hepatitis B, these laureate yellow film-coated tablets are supplied in secure bottles of 30 tablets each. Their esteemed quality is maintained by strict adherence to medicine grade standards, providing patients with the lowest price and maximum therapeutic value. A prescription is required to ensure proper usage, with each unit boasting a stable two-year shelf life when stored below 30C.
Special Features & Competitive Advantages of Tenohep AF Tablets
Tenohep AF Tablets deliver an array of special features including a reliable 2-year shelf life, a safe film-coated appearance for easy oral administration, and exceptional efficacy in anti-HIV and chronic Hepatitis B treatment. The product's primary competitive advantages rest in its laureate manufacturer, Zydus Cadila, and the lowest price point among comparable eminent medicines. These highlighted attributes ensure both safety and affordability, making it suitable for diverse healthcare settings.
Efficient Supply, Transportation, and Certifications
With robust supply ability, Tenohep AF Tablets are efficiently dispatched across India's main domestic markets. Secure shipping and careful transportation protocols ensure product integrity from supplier to end user. Renowned certifications support its trusted reputation, confirming that each batch meets high pharmaceutical standards. Timely order fulfillment and reliable logistics enable traders and suppliers to guarantee prompt delivery, fortifying Tenohep AF Tablets as a preferred choice for India's healthcare providers.
Special Features & Competitive Advantages of Tenohep AF Tablets
Tenohep AF Tablets deliver an array of special features including a reliable 2-year shelf life, a safe film-coated appearance for easy oral administration, and exceptional efficacy in anti-HIV and chronic Hepatitis B treatment. The product's primary competitive advantages rest in its laureate manufacturer, Zydus Cadila, and the lowest price point among comparable eminent medicines. These highlighted attributes ensure both safety and affordability, making it suitable for diverse healthcare settings.
Efficient Supply, Transportation, and Certifications
With robust supply ability, Tenohep AF Tablets are efficiently dispatched across India's main domestic markets. Secure shipping and careful transportation protocols ensure product integrity from supplier to end user. Renowned certifications support its trusted reputation, confirming that each batch meets high pharmaceutical standards. Timely order fulfillment and reliable logistics enable traders and suppliers to guarantee prompt delivery, fortifying Tenohep AF Tablets as a preferred choice for India's healthcare providers.
FAQ's of Tenohep Af Tablets:
Q: How should Tenohep AF Tablets be stored to maintain their effectiveness?
A: Tenohep AF Tablets should be stored below 30C in their original bottle packaging to preserve their potency and maximize their shelf life of up to 2 years.Q: What is the primary usage of Tenohep AF Tablets?
A: Tenohep AF Tablets are primarily indicated for the treatment of chronic Hepatitis B and are also effective in anti-HIV therapy. They must be taken as prescribed by a healthcare professional.Q: When do Tenohep AF Tablets expire after manufacture?
A: Tenohep AF Tablets expire 24 months, or 2 years, after their date of manufacture. Always check the packaging for the expiration date before use.Q: Where are Tenohep AF Tablets manufactured and supplied from?
A: These tablets are manufactured by Zydus Cadila in India and supplied across various regions, ensuring wide accessibility within the country.Q: What is the process for obtaining Tenohep AF Tablets?
A: Tenohep AF Tablets require a valid prescription from a licensed healthcare provider. After obtaining a prescription, you can purchase them from authorized traders or suppliers.Q: How does the secure shipping process benefit buyers?
A: Secure shipping ensures that Tenohep AF Tablets arrive in optimal condition, maintaining their quality and safety through reliable transportation practices until they reach the end user.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti Drug Medicine Category
Tenofovir Alafenamide Tablets IP
Price 450 INR / Pack
Minimum Order Quantity : 100 Packs
Indication : Chronic Hepatitis B, HIV1
Dosage Form : Tablets
Molecular Formula : C21H29O5N6P
Pacakaging (Quantity Per Box) : 30 tablets per box
BHAVYA ENTERPRISES
GST : 19AAXFB3365N1ZK
GST : 19AAXFB3365N1ZK
Send InquiryOur Products
23/A/1/1, Canal Street, Shreebhumi, Kolkata, North Twenty Four ParganasNorth 24 Parganas - 700048, West Bengal, India
Madhav Kumar
(Partner)
Mobile :+917039884208, +918420179866, +918981434331
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
